Imberti, Jacopo Francesco
 Distribuzione geografica
Continente #
NA - Nord America 7.197
AS - Asia 6.462
EU - Europa 2.945
SA - Sud America 960
OC - Oceania 256
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 127
Totale 18.109
Nazione #
US - Stati Uniti d'America 6.930
SG - Singapore 2.073
CN - Cina 1.918
IT - Italia 1.044
BR - Brasile 744
HK - Hong Kong 730
VN - Vietnam 616
GB - Regno Unito 359
FI - Finlandia 305
KR - Corea 299
DE - Germania 274
BD - Bangladesh 265
AU - Australia 254
SE - Svezia 229
RU - Federazione Russa 195
FR - Francia 138
CA - Canada 127
ID - Indonesia 102
IN - India 91
AR - Argentina 78
MX - Messico 76
NL - Olanda 68
JP - Giappone 42
AE - Emirati Arabi Uniti 40
IQ - Iraq 40
TR - Turchia 40
PL - Polonia 38
ZA - Sudafrica 38
AT - Austria 35
PK - Pakistan 35
UA - Ucraina 33
CO - Colombia 32
BG - Bulgaria 31
EC - Ecuador 31
LT - Lituania 31
ES - Italia 30
UZ - Uzbekistan 22
VE - Venezuela 22
CL - Cile 20
MA - Marocco 20
EG - Egitto 18
IE - Irlanda 18
TH - Thailandia 17
KE - Kenya 16
RS - Serbia 16
MY - Malesia 15
SA - Arabia Saudita 14
AZ - Azerbaigian 13
BE - Belgio 13
CZ - Repubblica Ceca 12
RO - Romania 12
DZ - Algeria 11
JM - Giamaica 11
PY - Paraguay 11
TW - Taiwan 11
TN - Tunisia 10
BO - Bolivia 9
GT - Guatemala 9
JO - Giordania 9
OM - Oman 9
CR - Costa Rica 8
KZ - Kazakistan 8
PH - Filippine 8
PT - Portogallo 8
HU - Ungheria 7
NP - Nepal 7
PE - Perù 7
TT - Trinidad e Tobago 7
AL - Albania 6
CH - Svizzera 6
GE - Georgia 6
SV - El Salvador 6
CU - Cuba 5
DO - Repubblica Dominicana 5
IL - Israele 5
IR - Iran 5
UY - Uruguay 5
BY - Bielorussia 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
CY - Cipro 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
LB - Libano 2
MT - Malta 2
Totale 17.921
Città #
Singapore 1.286
Santa Clara 1.008
Hefei 931
Ashburn 905
Hong Kong 722
San Jose 691
Council Bluffs 341
Seoul 299
Helsinki 246
Beijing 242
Fairfield 238
Chandler 220
Los Angeles 218
London 215
Ho Chi Minh City 202
New York 200
Nyköping 180
Perth 167
The Dalles 166
Hanoi 134
Dallas 120
Chicago 116
Milan 108
Houston 103
Woodbridge 96
Munich 91
Seattle 90
Bologna 89
Buffalo 88
Wilmington 79
Rome 77
Cambridge 72
Lauterbourg 71
São Paulo 71
Shanghai 70
Jakarta 69
Modena 55
Kent 52
Moscow 51
Salt Lake City 48
San Diego 47
Mexico City 40
Orem 40
Sydney 40
Lappeenranta 39
Boardman 38
Montreal 37
Princeton 37
Frankfurt am Main 36
Ann Arbor 34
Tokyo 34
Da Nang 33
Toronto 32
Haiphong 29
Sofia 29
Atlanta 28
Columbus 27
Denver 26
Warsaw 26
Schiffdorf 25
Southend 25
Johannesburg 24
Amsterdam 23
Nuremberg 23
Phoenix 23
Redondo Beach 23
Brooklyn 22
Lakewood 22
Turin 21
Dublin 20
Memphis 20
Naples 20
Tashkent 20
Guangzhou 19
Rio de Janeiro 19
Turku 19
Vienna 19
Parma 18
San Francisco 18
Stockholm 18
Boston 17
Düsseldorf 17
North Bergen 17
Baghdad 16
Portsmouth 16
Belo Horizonte 15
Campinas 15
Chennai 15
Hải Dương 15
Kilburn 15
Tampa 15
Biên Hòa 14
Elk Grove Village 14
Miami 14
Curitiba 13
Melbourne 13
Porto Alegre 13
Belgrade 12
Mumbai 12
Nairobi 12
Totale 11.610
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 506
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 326
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 307
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 306
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 291
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 284
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 283
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 263
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 262
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 260
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 242
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 229
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 229
Remote monitoring and telemedicine in heart failure: implementation and benefits 223
Atrial fibrillation burden: Stepping beyond the categorical characterization 221
Progression of Atrial Fibrillation after Cryoablation 221
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 217
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 209
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 206
What do we do about atrial high rate episodes? 206
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 205
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 205
Single-lead VDD pacing: a literature review on short-term and long-term performance 203
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 203
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 202
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 196
Female sex and stroke in atrial fibrillation: an intriguing relationship 193
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 193
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 191
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 184
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 181
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 181
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 181
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 177
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 175
Atrial fibrillation in pneumonia: what clinical implications at long-term? 175
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 174
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 172
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 170
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 170
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 167
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 166
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 162
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 161
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 161
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 159
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 157
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 156
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 155
Clinical decisions for appropriate management of patients with atrial fibrillation 155
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 153
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 149
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 148
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 145
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 144
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 142
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 142
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 142
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 141
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 139
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 138
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 134
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 133
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 132
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 131
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 130
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 130
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 129
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 127
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 126
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 126
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 126
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 125
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 125
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 121
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 120
Antiarrhythmic drugs in the era of atrial fibrillation ablation 119
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 118
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 116
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 115
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 115
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 112
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 112
Mobile health technology in atrial fibrillation 112
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 110
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 110
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 109
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 109
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 108
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 106
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 104
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 104
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 102
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 101
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 100
Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association 99
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 97
Atrial fibrillation screening: The importance of the patient perspective 93
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 91
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? 85
Totale 16.666
Categoria #
all - tutte 83.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022539 0 0 14 24 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20269.430 679 430 805 1.129 975 476 1.306 537 1.128 787 667 511
2026/20271.144 516 595 33 0 0 0 0 0 0 0 0 0
Totale 18.109